Form 4: ADMA Biologics CFO Brad L. Tade Reports Changes in Beneficial Ownership
SEC Form 4 Filing
CFO Brad L. Tade reports changes in beneficial ownership of ADMA Biologics, Inc. stock due to tax withholding upon vesting of restricted stock units.
Summary
- On February 26, 2025, ADMA Biologics CFO Brad L. Tade had 5,280 shares of common stock withheld by the issuer to satisfy mandatory tax withholding requirements upon the vesting of restricted stock units (RSUs) at a price of $15.78 per share.
- This was not an open market sale.
- Following the transaction, Tade beneficially owns 256,380 shares of ADMA Biologics common stock.
- This total includes unvested RSUs granted on various dates and shares acquired through open market purchases and RSU vesting after tax withholdings.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't contain information that would significantly sway investor sentiment positively or negatively.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's stock ownership and recent changes due to tax obligations related to RSU vesting.
Key Dates
| Date | Description |
|---|---|
| June 26, 2023 | 56,250 unvested RSUs granted, vesting quarterly over four years. |
| February 26, 2024 | 37,500 unvested RSUs granted, vesting quarterly over four years. |
| July 24, 2024 | 72,400 RSUs granted, vesting quarterly over four years. |
| February 19, 2025 | 62,227 unvested RSUs granted, vesting quarterly over four years. |
| February 26, 2025 | Transaction date: 5,280 shares withheld for tax obligations at $15.78. |
| February 27, 2025 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.